학술논문
Allogeneic Peripheral Blood Stem Cell Transplantation is a Promising and Safe Choice for the Treatment of Refractory/Relapsed Acute Myelogenous Leukemia, Even with a Higher Leukemia Burden
Document Type
Article
Author
Source
In Biology of Blood and Marrow Transplantation April 2013 19(4):653-660
Subject
Language
ISSN
1083-8791